Biomarker profiles are tumor-specific and can predict sensitivity or resistance to targeted therapy or immune checkpoint inhibition, enabling more individualized treatment selection than histology ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...

Stefanie Houseknecht, PharmD, explains how oncology pharmacists support biomarker testing, targeted therapy selection, and patient education in lung cancer care. As lung cancer treatments become more ...

Even as biomarker testing has become increasingly important for selecting the right lung cancer treatment, the time it takes to order these tests hasn't improved. Overall, the time from biopsy to ...

A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma ...

Gene therapy lung cancer biomarker: Genprex and Roche Diagnostics are partnering to validate a TROP2 test that identifies ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 ...

Please provide your email address to receive an email when new articles are posted on . Time from biopsy to receipt of molecular testing results decreased, but most of the improvement occurred at the ...

Now Available to Health Care Providers in Dallas-Fort Worth and San Antonio DALLAS, July 22, 2026 /PRNewswire/ -- Texas-based Cizzle Bio, Inc., a biotechnology company advancing biomarker blood tests ...

Add Yahoo as a preferred source to see more of our stories on Google. There are 24 states that mandate insurance companies to cover the cost of a biomarker test, according to the American Cancer ...

Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...